Dogwood Therapeutics Statistics Share Statistics Dogwood Therapeutics has 1.91M
shares outstanding. The number of shares has increased by 43.46%
in one year.
Shares Outstanding 1.91M Shares Change (YoY) 43.46% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.62M Failed to Deliver (FTD) Shares 822 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 34.24K, so 1.79% of the outstanding
shares have been sold short.
Short Interest 34.24K Short % of Shares Out 1.79% Short % of Float 2.03% Short Ratio (days to cover) 5.03
Valuation Ratios The PE ratio is -0.21 and the forward
PE ratio is -1.77.
Dogwood Therapeutics's PEG ratio is
0.
PE Ratio -0.21 Forward PE -1.77 PS Ratio 0 Forward PS 0.1 PB Ratio 0.04 P/FCF Ratio -0.29 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Dogwood Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.21,
with a Debt / Equity ratio of 0.24.
Current Ratio 5.21 Quick Ratio 5.21 Debt / Equity 0.24 Debt / EBITDA -1.27 Debt / FCF -1.77 Interest Coverage -132.63
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.03M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -503 Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 125.44% in the
last 52 weeks. The beta is 1.91, so Dogwood Therapeutics's
price volatility has been higher than the market average.
Beta 1.91 52-Week Price Change 125.44% 50-Day Moving Average 5.24 200-Day Moving Average 5.43 Relative Strength Index (RSI) 57.39 Average Volume (20 Days) 724,820
Income Statement
Revenue n/a Gross Profit -12.18K Operating Income -12.23M Net Income -12.35M EBITDA -12.25M EBIT -12.26M Earnings Per Share (EPS) -12.52
Full Income Statement Balance Sheet The company has 14.85M in cash and 15.59M in
debt, giving a net cash position of -737.71K.
Cash & Cash Equivalents 14.85M Total Debt 15.59M Net Cash -737.71K Retained Earnings -73.82M Total Assets 96.69M Working Capital 12.82M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.79M
and capital expenditures 5, giving a free cash flow of -8.79M.
Operating Cash Flow -8.79M Capital Expenditures 5 Free Cash Flow -8.79M FCF Per Share -8.55
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
